Lab-designed molecule reduces amyloid beta, the protein linked to Alzheimer's disease, in mice

A probe squad led by the Molecular and Cellular Neurobiotechnology radical astatine the Institute for Bioengineering of Catalonia (IBEC), successful collaboration with Míriam Royo's laboratory astatine the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), the University of Barcelona (UB) and the Institute for Research successful Biomedicine (IRB Barcelona), has identified a synthetic peptide that reduces the accumulation of amyloid beta (Aβ).